NASDAQ:MGCD - MGC Diagnostics Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close$11.03
Today's Range$11.03 - $11.03
52-Week Range$6.24 - $11.20
Average Volume15,965 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
MGC Diagnostics Corporation is a medical technology company, which offers cardiorespiratory health solutions. The Company designs, markets and sells non-invasive cardiorespiratory diagnostic products. It sells its products internationally through distributors and in the United States through a direct sales force targeting specialists located in hospitals, university-based medical centers, medical clinics, physician offices, pharmaceutical companies, medical device manufacturers and clinical research organizations (CROs). Its cardiorespiratory diagnostic products measure flow and respiratory pressures and, in most cases analyze the inhaled and exhaled gases, such as oxygen and carbon dioxide. Its products include pulmonary function (PFT) and gas exchange (GX) testing products. The Company's pulmonary function products are divided into four product categories: Spirometry, Complete Pulmonary Function, Body Plethysmography and Specialty Products.

Receive MGCD News and Ratings via Email

Sign-up to receive the latest news and ratings for MGCD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Current SymbolNASDAQ:MGCD
Previous SymbolNASDAQ:ANGN



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

MGC Diagnostics (NASDAQ:MGCD) Frequently Asked Questions

What is MGC Diagnostics' stock symbol?

MGC Diagnostics trades on the NASDAQ under the ticker symbol "MGCD."

How were MGC Diagnostics' earnings last quarter?

MGC Diagnostics Corp (NASDAQ:MGCD) released its quarterly earnings results on Wednesday, September, 7th. The medical equipment provider reported $0.06 EPS for the quarter. The medical equipment provider earned $9.90 million during the quarter, compared to analysts' expectations of $9.20 million. View MGC Diagnostics' Earnings History.

Has MGC Diagnostics been receiving favorable news coverage?

Press coverage about MGCD stock has trended somewhat positive recently, according to InfoTrie. The research group ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. MGC Diagnostics earned a news impact score of 1.7 on InfoTrie's scale. They also gave headlines about the medical equipment provider a news buzz of 6.0 out of 10, indicating that recent news coverage is somewhat likely to have an impact on the company's share price in the near term.

What other stocks do shareholders of MGC Diagnostics own?

Who are MGC Diagnostics' key executives?

MGC Diagnostics' management team includes the folowing people:
  • Greg Greenberg, Chairman of the Board
  • Matthew S. Margolies, President (Age 50)
  • Todd M. Austin, Chief Executive Officer (Age 54)
  • Larry Robert Degen, Interim Chief Financial Officer, Chief Accounting Officer, Secretary (Age 62)
  • Hendrik Struik, Independent Director (Age 49)

How do I buy shares of MGC Diagnostics?

Shares of MGCD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is MGC Diagnostics' official website?

The official website for MGC Diagnostics is

How can I contact MGC Diagnostics?

MGC Diagnostics' mailing address is 350 Oak Grove Pkwy, SAINT PAUL, MN 55127-8507, United States. The medical equipment provider can be reached via phone at +1-651-4844874 or via email at [email protected]

MarketBeat Community Rating for MGC Diagnostics (NASDAQ MGCD)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  87 (Vote Outperform)
Underperform Votes:  60 (Vote Underperform)
Total Votes:  147
MarketBeat's community ratings are surveys of what our community members think about MGC Diagnostics and other stocks. Vote "Outperform" if you believe MGCD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MGCD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/26/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel